FDA Inspection
Hill Dermaceuticals, Inc.Hill Dermaceuticals, Inc. – FDA Inspection, Oct 14, 2025
Record Details
This FDA Inspection record concerns Hill Dermaceuticals, Inc., with an inspection on October 14, 2025, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 617a3a8f-c004-48f6-9b6f-7402e8bc6cd3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1287088
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- FDCA 582(g)(1)(C)Enhanced systems - verification
- FDCA 582(b)(4)Systems in place to comply with verification requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hill Dermaceuticals, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 11, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hill Dermaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.